Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

Share Price is delayed by 15 minutes
Get Live Data
85.00    0.00 (0.00%)
Bid:
80.00
Ask:
90.00
Spread: 10.00 (12.50%)
Market Cap: £15.92m
MAI Live PriceLast checked at - London Stock Exchange

Intraday Maintel Share Chart

Director Appointment

11 May 2023 14:20

RNS Number : 1486Z
Maintel Holdings PLC
11 May 2023
Β 

Maintel Holdings Plc ("Maintel" or "the Company")

Director Appointment

Β 

Maintel Holdings Plc, a leading provider of cloud and managed communications services, is pleased to announce the appointment of Clare Bates as a Non-Executive Director with immediate effect.

Mrs. Bates has over 20 years' experience in senior human resources (HR) roles, gained in both private and public companies. Between 2009 and 2017 she held the position of HR and Transformation Director at SSP Limited, the global software company, where she had the responsibility of leading the global people agenda through multiple corporate events. Prior to SSP Limited, she held senior HR roles at Saint Gobain plc, E.ON AG, and Powergen plc, acquiring significant knowledge of organisational development, employee engagement, remuneration, recruitment and corporate governance. Most recently she has been applying her knowledge and experience as a consultant across a range of sectors.

Commenting on her appointment, Carol Thompson, Executive Chair of the Company said:

"I am delighted to welcome Clare to the board. I am sure her wealth of experience in delivering excellent business outcomes through the effective management and engagement of people in our sector will be of great benefit to the Company as we look to deliver on our future development and growth."

Β 

For further information please contact:

Maintel Holdings Plc

Carol Thompson, Executive Chair

Gab Pirona, Chief Financial Officer

Dan Davies, Chief Technology Officer

0344 871 1122

finnCap (Nomad and Broker)

Jonny Franklin-Adams / Emily Watts / Fergus Sullivan (Corporate Finance)

Sunila de Silva (Corporate Broking)

020 7220 0500

Β 

Β 

Regulatory Disclosures:

INFORMATION REQUIRED UNDER RULE 17 AND SCHEDULE 2, PARAGRAPH (G) OF THE AIM RULES FOR COMPANIES ("AIM RULES")

Full name:

Clare Elizabeth Bates (nΓ©e Shakespeare)

Age:

59

Shareholding in the Company:

None

Current directorships and/or partnerships:

Historic directorships and/or partnerships (within the last five years):

Β 

Rouncil Services Limited

ReCOM: Bridging the IT Gap in the Community Ltd

Β 

Β 

There is no further information to be disclosed in relation to the director appointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM Rules.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHABMJTMTBBBTJ
Date   Source Headline
6th Jul 20205:14 pmRNSDirector Dealings
1st Jul 20205:05 pmRNSDirector/PDMR Shareholding & Total Voting Rights
30th Jun 20204:28 pmRNSBoard Changes
30th Jun 20204:10 pmRNSResult of AGM
5th Jun 20202:51 pmRNSHolding(s) in Company
5th Jun 20207:41 amRNSHolding(s) in Company
4th Jun 20204:01 pmRNSDirector Shareholding and Total Voting Rights
4th Jun 202012:26 pmRNSPosting of Annual Report and Accounts
1st Jun 20205:18 pmRNSDirector/PDMR Shareholding
1st Jun 20207:00 amRNSFinal Results
30th Apr 20204:46 pmRNSDirector/PDMR Shareholding
6th Apr 20207:00 amRNSHolding(s) in Company
1st Apr 20204:22 pmRNSDirector/PDMR Shareholding
1st Apr 20201:52 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSHolding(s) in Company
30th Mar 20207:00 amRNSCOVID-19 and Results Update
2nd Mar 20202:58 pmRNSDirector/PDMR Shareholding
21st Feb 20204:15 pmRNSGrant of Options
5th Feb 20203:00 pmRNSDirector/PDMR Shareholding
24th Jan 202011:00 amRNSHolding(s) in Company
22nd Jan 20204:20 pmRNSHolding(s) in Company
17th Jan 202010:28 amRNSHolding(s) in Company
15th Jan 20205:31 pmRNSHolding(s) in Company
10th Jan 20204:53 pmRNSHolding(s) in Company
9th Jan 20207:00 amRNSTrading Statement
2nd Jan 20204:10 pmRNSNotification of Transactions of Directors/PDMR
2nd Dec 20195:00 pmRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSDirector/PDMR Shareholding
16th Oct 20197:00 amRNSGrant of Options
11th Oct 20194:35 pmRNSDirector/PDMR Shareholding
9th Oct 20194:43 pmRNSDirector/PDMR Shareholding
4th Oct 20197:00 amRNSBoard Update
3rd Oct 20192:30 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSAppointment of Chief Executive Officer
2nd Sep 20197:00 amRNSInterim Results
30th Aug 20192:52 pmRNSDirector/PDMR Shareholding
30th Jul 20197:26 amRNSDirector/PDMR Shareholding
19th Jul 20191:00 pmRNSDirector Update, Director Shareholding and TVR
3rd Jun 20193:30 pmRNSNotification of Transactions of Directors
31st May 20198:00 amRNSDirector/PDMR Shareholding
20th May 20191:36 pmRNSDirector/PDMR Shareholding and Total Voting Rights
13th May 20194:26 pmRNSResult of AGM
3rd May 20197:00 amRNSBoard Change
1st May 20197:00 amRNSDirector/PDMR Shareholding
30th Apr 20194:16 pmRNSGrant of Options
10th Apr 20193:01 pmRNSNotice of AGM
1st Apr 201911:29 amRNSDirector/PDMR Shareholding
25th Mar 201910:00 amRNSDirector Dealing and Total Voting Rights
18th Mar 20197:00 amRNSFinal Results
4th Mar 20197:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.